PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $80,416 | -47.6% | 25,529 | -51.6% | 0.00% | -50.0% |
| Q2 2020 | $153,578 | +3.2% | 52,776 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $148,828 | -39.7% | 52,776 | -30.6% | 0.00% | -33.3% |
| Q4 2019 | $246,623 | +50.2% | 76,001 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $164,162 | -31.2% | 76,001 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $238,643 | -15.6% | 76,001 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $282,724 | +28.3% | 76,001 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $220,403 | +10.3% | 76,001 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $199,883 | +12.3% | 76,001 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $178,000 | +44.7% | 76,001 | +81.3% | 0.00% | +100.0% |
| Q1 2018 | $123,000 | -42.0% | 41,923 | -45.9% | 0.00% | -50.0% |
| Q4 2017 | $212,000 | – | 77,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |